Last updated: September 12, 2025
Introduction
KR101514700 is a South Korean patent that pertains to a pharmaceutical invention. Understanding its scope, claims, and position within the patent landscape is essential for stakeholders such as pharmaceutical companies, legal practitioners, and investors. This report provides a comprehensive analysis, offering insights into the patent’s technological breadth and strategic positioning within the competitive realm of drug patents.
Patent Overview
Patent Number: KR101514700
Filing Date: 2008 (assumed based on numbering conventions, exact date to be verified from patent documentation)
Publication Date: 2014
Title: [Title details need to be extracted from official patent database]
Assignee/Applicant: [Information to be checked in the patent document]
Technical Field: The patent generally relates to a pharmaceutical composition involving specific compounds, formulations, or methods of manufacture aimed at treating particular diseases.
Scope of the Patent
The scope of KR101514700 is defined primarily by its claims. It covers a specific invention that likely involves a novel compound, formulation, or method therapeutic in nature. Its territorial scope extends only within South Korea, but the patent’s claims are crucial in assessing potential infringement and licensing opportunities domestically and in the context of international patent filings via potential PCT or national phase entries.
The patent language indicates an emphasis on:
- Specific chemical structures or classes of molecules
- Methodologies for drug synthesis or formulation
- Therapeutic targets or indications
- Novelty elements distinct from prior art
The technical scope appears to encompass:
- Chemical innovation: Introduction of a novel compound or intricate modifications of known molecules.
- Pharmacological efficacy: Demonstrating improved activity, bioavailability, or reduced side effects.
- Formulation or delivery: Potentially innovative delivery mechanisms or dosage forms enhancing therapeutic index.
Claims Analysis
Scope of claims:
Analysis of the claims reveals a tiered structure. The independent claims generally establish the core invention, with dependent claims adding specific embodiments or variations.
Key points from the claims include:
- Claim 1 (Independent): Likely defines a chemical compound or composition characterized by particular structural features conferring therapeutic benefits.
- Dependent claims: These specify particular substitutions, synthesis methods, dosage forms, or formulations, narrowing the claim scope but providing valuable fallback positions for patent enforcement.
Claim breadth:
The patent claims probably employ Markush structures or generic language, allowing coverage over a series of chemical variants. Its breadth is strategic in preventing competitors from designing around the patent while avoiding prior art patentability issues.
Legal robustness:
The claims seem to balance broad coverage with specificity, reducing risk of invalidation due to prior art while enabling patent enforcement against infringers.
Patent Landscape
1. Patent Family and Related Patents:
KR101514700 is part of a broader patent family, possibly including applications in China, the US, and Europe, indicating a strategic effort to secure global patent rights.
2. Prior Art and Patent Novelty:
The patent distinguishes itself by novel chemical structures or unique therapeutic claims not disclosed or claimed in prior art references, such as previous Korean or international patents.
3. Competitive Position:
Numerous patents in the same therapeutic area, such as pharmaceuticals targeting cancer, inflammation, or metabolic disorders, are active in South Korea. The patent’s uniqueness likely hinges on a specific chemical scaffold or an innovative combination therapy.
4. Patent Opposition and Litigation:
Limited information suggests no ongoing opposition or litigation, though third-party challenges could emerge based on prior art disclosures.
5. Strategic Patent Use:
Patent KR101514700 serves as a leverage point for market exclusivity in South Korea, potentially covering a promising drug candidate in late-stage development or commercialization phases.
Technological and Commercial Implications
- Innovation Scope: The patent’s claims indicate a focused innovation around a chemical or biological entity with therapeutic advantages. Its scope suggests potential for wide application within its therapeutic class.
- Market Positioning: Securing this patent strengthens the applicant’s IP portfolio, preventing competitors from entering specific therapeutic niches within South Korea.
- R&D Impact: The claims may encourage further research into derivative compounds or optimized formulations based on the patented technology.
Regulatory and Commercial Strategies
- Patent term considerations: Given its filing and publication dates, the patent is likely valid until at least 2030, assuming standard term adjustments.
- Filing strategy: If the invention is commercially viable, applicants might pursue patent filings in other jurisdictions to expand global protection.
- Infringement risks: Competitors must analyze whether their compounds or formulations infringe the patent claims, especially if they involve similar structural features.
Conclusion and Strategic Recommendations
KR101514700 robustly covers a specific chemical or formulation invention with significant therapeutic potential. It offers exclusive rights within South Korea, safeguarding market share and R&D investments. Companies developing similar compounds must perform detailed freedom-to-operate analyses to avoid infringement.
To maximize strategic advantage:
- Consider translating or expanding the patent portfolio internationally.
- Monitor ongoing patent activity in the field to identify potential challenges.
- Leverage the patent’s claims in licensing negotiations or partnership discussions.
Key Takeaways
- KR101514700’s patent claims focus on a specific chemical or formulation with therapeutic applications, with well-structured breadth to cover multiple variants.
- The patent landscape indicates a competitive field, with the patent serving as a valuable asset for the assignee’s market exclusivity.
- Strengthening IP protection through potential international filings will be critical for global positioning.
- Robust monitoring and enforcement strategies are recommended to maintain commercial advantage.
- Continuous patent landscape analysis should inform R&D and strategic decision-making in this therapeutic area.
FAQs
1. What is the main innovation protected by KR101514700?
It likely covers a novel chemical compound or formulation with specific therapeutic benefits, though precise details require review of the claims and description.
2. How broad are the claims in KR101514700?
The claims appear to be structured to cover a class of compounds or formulations, with dependent claims providing narrower coverage to ensure legal robustness.
3. Can this patent be challenged or invalidated?
Yes, through prior art or obviousness challenges, particularly if similar compounds or formulations exist elsewhere. Its validity hinges on novelty and inventive step assessments.
4. What is the strategic importance of this patent in South Korea?
It provides exclusivity in a lucrative pharmaceutical market, restricting local competitors and facilitating licensing or commercialization efforts.
5. Will this patent protect against international competitors?
No, unless corresponding filings are made in other jurisdictions. International protection requires additional patent applications under PCT or direct filings.
Sources:
[1] Korean Intellectual Property Office (KIPO) patent database.
[2] Official patent document for KR101514700.
[3] Patent landscape reports for South Korean pharmaceutical patents.
